Pfizer (PFE) Drags on XLV ETF
Tweet
Share
E-mail
Health Care Select Sector SPDR Holdings (NYSE: XLV) was down early Tuesday after Pfizer (NYSE: PFE) reported Q1 earnings and offered a FY12 outlook.
Pfizer Inc makes up 11.76 percent of XLV ETF, its second largest holding behind Johnson & Johnson (NYSE: JNJ).
After trading to as low as $22.55 (down about 1.5 percent), Pfizer shares began grinding back to even as the broader stock market lifted the pharma giant. Stocks surged at 10am ET as data from the Institute of Supply Management came in better than expected. While Pfizer shares are now flat, the XLV ETF is up 0.5 percent.
Pfizer Inc makes up 11.76 percent of XLV ETF, its second largest holding behind Johnson & Johnson (NYSE: JNJ).
After trading to as low as $22.55 (down about 1.5 percent), Pfizer shares began grinding back to even as the broader stock market lifted the pharma giant. Stocks surged at 10am ET as data from the Institute of Supply Management came in better than expected. While Pfizer shares are now flat, the XLV ETF is up 0.5 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
Create E-mail Alert Related Categories
ETFsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
